Cerus Corporation (CERS) Drops 5.19% on January 27

Equities Staff |

Cerus Corporation (CERS) was one of the Russell 2000's biggest losers for Wednesday January 27 as the stock slid 5.19% to $5.11, a loss of $-0.28 per share. Starting at an opening price of $5.35 a share, the stock traded between $5.10 and $5.42 over the course of the trading day. Volume was 609,863 shares over 4,413 trades, against an average daily volume of 962,738 shares and a total float of 97.14 million.

The losses send Cerus Corporation down to a market cap of $496.38 million. In the last year, Cerus Corporation has traded between $6.66 and $3.82, and its 50-day SMA is currently $5.76 and 200-day SMA is $5.17.

Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Cerus Corporation is based out of Concord, CA and has some 144 employees. Its CEO is William M. Greenman.

For a complete fundamental analysis analysis of Cerus Corporation, check out Equities.com’s Stock Valuation Analysis report for CERS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IGEN Networks Corp.

iGen Networks Corp is engaged in investing in and managing for growth private high-tech companies that offer products and services in the domains of wireless broadband, software as a service,…

Private Markets

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…